News

Previous research has suggested that breathing sounds could be regarded as potential biomarkers for OSA, which could be recorded via the microphones found in most smartphone devices.

Findings from the aV1ation trial highlight the challenges of modern autism clinical research and outcomes of care.

Vaccine effectiveness was slightly lower in patients with underweight, who also have the lowest levels of vaccine uptake across all ages.

There was an increased odds of liver injury per exposure-mixture quartile increase for organochlorine pesticides, PBDEs) perfluoroalkyl substances, and metals.

Investigators suggest that health care providers have a “unique opportunity” to facilitate shared decision making and empower patients and caregivers by involving them in the practice of eczema care.

New findings suggest low-dose rivaroxaban plus aspirin was associated with lower VTE risk compared with aspirin alone.

Reducing sedentary time and increasing physical activity may reduce the global burden of premature deaths and CVD.

Previous research had resulted in conflicting results regarding the drug survival of guselkumab, which was shown to be highest among several biologics featured in this larger study.

Both the incidence and prevalence of the liver disease were higher in men than they were in women.

Washington DC, Hawaii, Oklahoma, California, Tennessee, West Virginia, Mississippi, Oregon, Washington, Louisiana, Kentucky, and New York all had HBV-related mortality rates higher than the national average.

A faster rate and central location of GCC thinning was associated with lower vision-related quality of life.

Data show the lifetime risk of late AMD ranged from 4.4% for carriers of the nonrisk genotype to 9.4% and 26.8% for heterozygous and homozygous carriers.

Nearly 40% of patients with prurigo nodularis reached clearance or almost-clearance of skin lesions following treatment with nemolizumab.

Weekly 300 mg doses of dupilumab were associated with significant, clinically meaningful improvements by week 24 in patients with eosinophilic esophagitis

Travis Vandergriff, MD, discusses the unique collaboration with ophthalmologists and urologists in the rare skin condition.

The interventional pulmonology specialist discusses new technology and devices available for diagnosing lung cancer.

An analysis of PSOARING 1 and 2 data show the topical therapy is efficacious across a wide spectrum of psoriatic disease and patient demographics.

Women with the highest PTSD symptoms level experienced significantly worse rates of change regarding learning and working memory.

Event rates were inversely proportional to kidney function in patients with chronic coronary disease.

Tenofovir was linked to a decreased incidence rate of HCC compared to entecavir. However, this difference was not considered statistically significant.

According to the results, individuals with SCT who previously had COVID-19 also had various preexisting kidney conditions that were associated with poor outcomes.

A substantial number of individuals (nearly 40%) reached arterial stenosis of at least 50%, according to the findings.

The majority of patients in the phase 2 study met the primary efficacy endpoint of a greater than or equal to a 10% reduction in total stool output over the 6-week efficacy evaluation period.

The increase was highest for Hispanic and non-Hispanic Black Women.

Despite an increased risk of new-onset psoriasis from TNFi treatment, investigators considered the absolute risk to be “modest”, with 241 patient-years of exposure needed for 1 additional event.

Varenicline was efficacious at weeks 12, 24, and 52 of the trial compared with placebo in a smoking cessation program.

During the analysis, investigators became fascinated by how many patients entered the buprenorphine treatment program for OUD having already been taking the drug without a prescription.

Dr. Remo Panaccione speaks on promising long-term data of ustekinumab for Crohn's disease and ulcerative colitis, and how it could function as either a first-line treatment or alternative option for patients who were previously exposed biologic therapies.